Mechanisms of mast cell directed carbon nanotube toxicity
肥大细胞定向碳纳米管毒性机制
基本信息
- 批准号:9265096
- 负责人:
- 金额:$ 42.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-10 至 2020-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAllergensAllergicAllergic DiseaseAsthmaBiophysicsCarbon NanotubesCardiovascular systemCell DegranulationCell Surface ReceptorsChargeChemicalsDataDefectDermatitisDevelopmentDoseEngineeringExcisionFunding AgencyGeneticGrantHealthHybridsImmune responseImmunologyIn VitroInbred Strains MiceInbreedingInvestigationLeadLibrariesLungMediatingMedicineMetalsMissionModelingMouse StrainsMusNanotechnologyNational Institute of Environmental Health SciencesNatureOccupational ExposureOutcomePathway interactionsPharmacologic SubstancePolicy MakerPolygenic TraitsProcessProductionPropertyProteinsRecombinant Inbred StrainResearchRisk AssessmentRoleSR-BI receptorSafetyScienceSerum ProteinsShapesSignal PathwaySignal TransductionSilverSiteSocietiesSustainable DevelopmentTechnologyTestingToxic effectToxicogeneticsWorkallergic responsebasecombinatorialcompliance behaviorconsumer productdensitydesigngenome wide association studymast cellmaterials sciencemetallicitynanonanomaterialsnanomedicinenanoparticlenanotherapeuticnovelpathogenphysical propertypreventprotein Epublic health relevanceresponsesafety engineeringscreeningtitanium dioxidetooltranscriptome sequencingtranscriptomicsuptake
项目摘要
DESCRIPTION (provided by applicant): Engineered nanomaterials (ENMs) have unique physicochemical properties with potential to impact diverse aspects of society. While the research and proposed applications of ENMs continue to grow rapidly, the health and safety of ENMs still remains a major concern to the public as well as to policy makers and funding agencies. While there has been considerable investigation into the properties of ENMs that elicit toxicity, little work has focused on the ability of ENMs to promote or exacerbate allergic disease.
Mast cell activation, which is central to development of allergic disease, has been an impediment to a number of pharmaceuticals and will likely represent a challenge for nanomedicines. Consequently, research on the health and safety implications of ENMs must address the potential for nanomedicines, nano-based consumer products or occupational exposures and the impact on initiation of allergic disease or exacerbation of underlying allergic diseases such as asthma. We have established, through the first cycle of this grant, that certain ENMs elicit mast cell activation either directly (via scavenger receptor B1) or indirectly (via IL-33) leading to adverse pulmonary and cardiovascular outcomes. Based on these findings, we have begun to investigate the properties of ENMs that promote mast cell degranulation or IL-33 production. Our preliminary data has suggested that the density of states or electronic energy levels of the ENM, as a yet unrecognized physicochemical property, contribute to mast cell degranulation through charge transfer to cell surface receptors or proteins. In addition, through preliminary studies, we have found that mast cell responses to ENMs are significantly variable across strains of inbred mice suggesting these responses are polygenic in nature. For this project, we hypothesize that ENM-directed mast cell activation is driven by key physical properties and chemical process at the nano-bio interface, which initiate novel signaling pathways, distinct from other pathogens/bulk allergens, driven by scavenger receptor B1 and this response is largely influenced by genetics. Our objectives are: 1) determine the ENM physicochemical properties responsible for mast cell activation through use of combinatorial library of ENMs; 2) establish the contribution of novel signaling pathways mediated through scavenger receptor B1 in the mast cell response to ENMs through cellular signaling studies; 3) elucidate the role of genetics in mast cell responses to ENM exposure using genome wide association analysis and transcriptomics with a hybrid mouse diversity panel of inbred and recombinant inbred strains. Understanding these mechanisms will allow us to design better models and in vitro screening tools to predict ENM toxicity, which will be important for risk assessment. More importantly, by gaining a more in depth understanding of the physicochemical properties that lead to mast cell degranulation, we will be able to engineer materials to prevent mast cell responses.
描述(由应用程序提供):工程纳米材料(ENM)具有独特的物理特性,具有影响社会潜水员方面的潜力。尽管ENM的研究和拟议的应用继续迅速增长,但ENM的健康和安全仍然是公众以及政策制定者和资助机构的主要关注点。尽管引起毒性的ENM的属性已经进行了大量投资,但很少有工作集中在ENM促进或加剧过敏性疾病的能力上。
肥大细胞激活是过敏性疾病发展的核心,一直是许多药物的障碍,可能代表纳米医学的挑战。因此,对ENM的健康和安全意义的研究必须解决纳米医学,基于纳米的消费产品或发生暴露的潜力,以及对过敏性疾病的倡议的影响或加剧基本的过敏性疾病,例如哮喘。通过该赠款的第一个循环,我们确定了某些ENM会直接(通过清除剂受体B1)或间接(通过IL-33)引起肥大细胞激活,从而导致不良的肺和心血管结局。基于这些发现,我们开始研究促进肥大细胞脱粒或IL-33产生的ENM的性质。我们的初步数据已经提出,作为尚未识别的物理特性,ENM的状态或电子能级的密度通过电荷转移到细胞表面受体或蛋白质来导致肥大细胞的脱粒。此外,通过初步研究,我们发现肥大细胞对ENM的反应在近交小鼠的菌株之间存在显着变化,这表明这些反应本质上是多基因的。对于这个项目,我们假设ENM指导的肥大细胞激活是由纳米生物生物界面的关键物理特性和化学过程驱动的,纳米生物生物界面启动了新型信号通路,这与其他病原体/散装过敏原不同,这是由自动vavenger接收器B1驱动的,并且这种反应在很大程度上受到遗传学的影响。我们的目标是:1)确定通过使用ENMS组合库来确定负责桅杆细胞激活的ENM物理属性; 2)通过细胞信号传导研究,在肥大细胞对ENM的反应中通过清道夫接收器B1介导的新型信号通路的贡献; 3)使用基因组广泛的关联分析和转录组学与杂交和重组近交菌株的混合小鼠多样性面板,阐明了遗传学在肥大细胞对ENM暴露的作用。了解这些机制将使我们能够设计更好的模型和体外筛查工具来预测ENM毒性,这对于风险评估非常重要。更重要的是,通过对导致肥大细胞脱粒的物理特性的深入了解,我们将能够设计材料以防止肥大细胞反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jared Michael Brown其他文献
Jared Michael Brown的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jared Michael Brown', 18)}}的其他基金
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology
二氧化硅肾病和病因不明的慢性肾脏病
- 批准号:
10029114 - 财政年份:2020
- 资助金额:
$ 42.1万 - 项目类别:
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology
二氧化硅肾病和病因不明的慢性肾脏病
- 批准号:
10461915 - 财政年份:2020
- 资助金额:
$ 42.1万 - 项目类别:
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology
二氧化硅肾病和病因不明的慢性肾脏病
- 批准号:
10212382 - 财政年份:2020
- 资助金额:
$ 42.1万 - 项目类别:
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology
二氧化硅肾病和病因不明的慢性肾脏病
- 批准号:
10682599 - 财政年份:2020
- 资助金额:
$ 42.1万 - 项目类别:
Nanoparticle-Protein Corona Structural Changes and Immunoreactivity
纳米颗粒-蛋白质电晕结构变化和免疫反应性
- 批准号:
8769110 - 财政年份:2014
- 资助金额:
$ 42.1万 - 项目类别:
Mechanisms of mast cell directed carbon nanotube toxicity
肥大细胞定向碳纳米管毒性机制
- 批准号:
8249077 - 财政年份:2010
- 资助金额:
$ 42.1万 - 项目类别:
Mechanisms of non-IgE Mast Cell Activation by Environmental Particulates
环境颗粒物激活非 IgE 肥大细胞的机制
- 批准号:
10424529 - 财政年份:2010
- 资助金额:
$ 42.1万 - 项目类别:
相似国自然基金
花生主要过敏原 Ara h 3 致敏的结构生物学基础
- 批准号:32372441
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
鱼类过敏原小清蛋白广谱性模拟抗原的精准构筑及构效关系研究
- 批准号:32372439
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
过敏原特异性Th2记忆前体细胞鉴定及其形成机制研究
- 批准号:82371740
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
白色念珠菌过敏原通过CGRP-IL-21-PIEZO1轴促进T细胞-小胶质细胞-神经元通讯介导瘙痒
- 批准号:82371797
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
过敏原RNA疫苗促进过敏性鼻炎中嗜酸性粒细胞分泌保护素D1诱导Treg产生机制
- 批准号:82371122
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
- 批准号:
10678307 - 财政年份:2023
- 资助金额:
$ 42.1万 - 项目类别:
ECHO Renewal for the INSPIRE Study Cohort
INSPIRE 研究队列的 ECHO 更新
- 批准号:
10745075 - 财政年份:2023
- 资助金额:
$ 42.1万 - 项目类别:
Early Life Pulmonary Infection, Microbiome and Trained Innate Immunity
生命早期肺部感染、微生物组和经过训练的先天免疫
- 批准号:
10677304 - 财政年份:2023
- 资助金额:
$ 42.1万 - 项目类别:
Neuronally-driven accumulation of glycolytic MafB+MHCIIhi IMs drive airway allergy
神经元驱动的糖酵解 MafB MHCIIhi IM 积累导致气道过敏
- 批准号:
10736048 - 财政年份:2023
- 资助金额:
$ 42.1万 - 项目类别:
Developing RNA Vaccines to Treat Peanut Hypersensitivity
开发治疗花生过敏的 RNA 疫苗
- 批准号:
10570339 - 财政年份:2023
- 资助金额:
$ 42.1万 - 项目类别: